Operating income decreased 271.2%
Operating income changed -271.2% from the comparable as-filed period.
-$1.5M→-$5.5M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →FNGR financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Gross margin moved 4812 bp higher
Gross margin changed +4812 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
0.45%→48.57%3 prior comparisons
Operating margin moved 195001 bp lower
Operating margin changed -195001 basis points from the comparable as-filed period.
-17.22%→-1967.24%3 prior comparisons
Operating cash flow increased 39.2%
Operating cash flow changed +39.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
-$1.9M→-$1.1M4 prior comparisons
Revenue decreased 96.7%
Revenue changed -96.7% from the comparable as-filed period.
$8.6M→$281,0763 prior comparisons
Gross profit increased 252.4%
Gross profit changed +252.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$38,740→$136,5153 prior comparisons
Research & development decreased 29.0%
Research & development changed -29.0% from the comparable as-filed period.
$77,540→$55,0283 prior comparisons
Current liabilities increased 39.4%
Current liabilities changed +39.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$36.8M→$51.3M4 prior comparisons
Inventory increased 164.2%
Inventory changed +164.2% from the comparable as-filed period.
$123,546→$326,4072 prior comparisons
Stock-based compensation decreased 29.8%
Stock-based compensation changed -29.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$107,750→$75,6474 prior comparisons
Cost of revenue decreased 98.3%
Cost of revenue changed -98.3% from the comparable as-filed period.
$8.6M→$144,5613 prior comparisons
SBC / revenue moved 2567 bp higher
SBC / revenue changed +2567 basis points from the comparable as-filed period.
1.25%→26.91%3 prior comparisons
Inventory / revenue moved 11470 bp higher
Inventory / revenue changed +11470 basis points from the comparable as-filed period.
1.43%→116.13%1 prior comparisons
R&D / revenue moved 1868 bp higher
R&D / revenue changed +1868 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
0.90%→19.58%3 prior comparisons
Gross margin moved 3027 bp higher
Gross margin changed +3027 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
1.80%→32.07%3 prior comparisons
Operating margin moved 27400 bp lower
Operating margin changed -27400 basis points from the comparable as-filed period.
-23.51%→-297.51%3 prior comparisons
Operating cash flow decreased 94.8%
Operating cash flow changed -94.8% from the comparable as-filed period.
-$1.2M→-$2.3M3 prior comparisons
Revenue decreased 92.3%
Revenue changed -92.3% from the comparable as-filed period.
$8.5M→$650,0893 prior comparisons
Research & development decreased 67.4%
Research & development changed -67.4% from the comparable as-filed period.
$172,652→$56,2803 prior comparisons
Cash & equivalents decreased 65.5%
Cash & equivalents changed -65.5% from the comparable as-filed period.
$2.9M→$987,3913 prior comparisons
Gross profit increased 36.7%
Gross profit changed +36.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$152,521→$208,4783 prior comparisons
Working capital decreased 53.4%
Working capital changed -53.4% from the comparable as-filed period.
$9.4M→$4.4M3 prior comparisons
Cost of revenue decreased 94.7%
Cost of revenue changed -94.7% from the comparable as-filed period.
$8.3M→$441,6113 prior comparisons
Inventory increased 230.4%
Inventory changed +230.4% from the comparable as-filed period.
$93,660→$309,4921 prior comparisons
SBC / revenue moved 1098 bp higher
SBC / revenue changed +1098 basis points from the comparable as-filed period.
1.51%→12.49%3 prior comparisons
Inventory / revenue moved 4650 bp higher
Inventory / revenue changed +4650 basis points from the comparable as-filed period.
1.11%→47.61%1 prior comparisons
R&D / revenue moved 662 bp higher
R&D / revenue changed +662 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
2.04%→8.66%3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.